A Boston Children's Hospital survey of 16 selected procedures at 13 pediatric hospitals in North America found a wide variation in radiopharmaceutical doses administered during nuclear medicine exams. The report reveals a need for consensus among nuclear physicians on appropriate doses for young patients.
A Boston Children's Hospital survey of 16 selected procedures at 13 pediatric hospitals in North America found a wide variation in radiopharmaceutical doses administered during nuclear medicine exams. The report reveals a need for consensus among nuclear physicians on appropriate doses for young patients.
Lead author Dr. S. Ted Treves and colleagues tracked the minimum and maximum administered radiopharmaceutical dose as well as the protocols used to determine appropriate doses. They found variations in maximum dosage for some drugs by a factor of 10 and differences in minimum dose by as much as a factor of 20. Survey results appeared in the June issue of the Journal of Nuclear Medicine.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.